Caris Life Sciences
Business Services · Texas, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
750 W John Carpenter Fwy Ste 800, Irving...Phone Number
(866) 771-8946Website
www.carislifesciences.comRevenue
$907.3 MillionStock Symbol
CAIIndustry
ZI Rank: 4
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
8
8
2
2
3
4
About Caris Life Sciences
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.Explore more
Caris Life Sciences Org Chart
JH
Senior Vice President, Chief Operations Offic...
SM
Senior Vice President
TM
Vice President, Clinical Programs
SS
Vice President, Operations
ME
Vice President, Genetic Operations
CB
Corporate Vice President, Strategy & Operatio...
MD
Corporate Vice President - Oncology Franchise
RK
Head Vice President, Diagnostic Partnering, P...
JX
Vice President, Clinical & Translational Rese...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caris Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Caris Life Sciences launches new products
Click to see if Caris Life Sciences had a recent Job posting/layoffs
Earning: See what the market has to say on Caris Life Sciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Caris Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Caris Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Caris Life Sciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Caris Life Sciences
Check out if Caris Life Sciences is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Caris Life Sciences as Masked Content
Find more new buyers
Compare Similar Companies to Caris Life Sciences
Compare insights from companies similar to Caris Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
$161.2M
501-1,000
Private
-
1996
Anuradha SinghalSenior Vice President, Chief Marketing Officer, Senior Laboratory Medical Director
Company Profile Activity
Activity Insights
Caris Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caris Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caris Life Sciences.
Caris Life Sciences financials insights
Gather financial insights about Caris Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Unspecified
$150M
2020
Unspecified
$310M
2021
Other Financing Round
$830M
2023
Debt
$400M
2025
Other Financing Round
$168M
IPO
$494M
2026
Debt
$1.2B
Caris Life Sciences Tech Stack
A closer look at the technologies used by Caris Life Sciences
Most Recent Scoops
Open Position
Person-Based
Events, Bioengineering, Artificial Intelligence
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Caris Life Sciences News & Media
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsJ.Caris Life Sciences Q2 Earnings Call Highlights
Caris Life Sciences (NASDAQ:CAI) reported record clinical volume and raised its full-year revenue outlook after second-quarter revenue increased 45% from a year earlier, driven by growth in molecular profiling services, higher average selling prices and an expanding commercial organization. The comCaris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Revenue growth of 45% driven by strong performance in molecular profiling services, including approximately 59,200 clinical cases, consisting of over 114,000 whole exome/whole transcriptome tests with over 345,000 total oncology tests Raises 2026 revenue guidance to $1.03 to $1.04...Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
IRVING, Texas, July 16, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report second quarter 2026 financial results on Wednesday, August 5, 2026. Caris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Caris Life Sciences
Sign Up For FreeTo access detailed company insights
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.... Read More
